Noxopharm Ltd.ASX: NOX

Appendix 4G and Corporate Governance Statement

· Issued by Noxopharm Ltd. via ASX

Filed with ASX ·

Noxopharm Limited. ABN 50 608 966 123 Level 20, Tower A, The Zenith, 821 Pacific Highway, Chatswood NSW 2067 AUSTRALIA Appendix 4G and Corporate Governance Statement Sydney, 16 October 2026: Innovative biotech company Noxopharm Limited (ASX:NOX) attached the following documents in relation to...

View Attachment

6ix hasn’t read this filing yet.

Noxopharm Ltd. on 6ix

Earlier from Noxopharm

Later from Noxopharm

All Noxopharm news releases